Patton, John S.
Dance Pharmaceuticals, Inc.,
United States
2025 Rank: 226426
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Immunology
Rank in SubField 1: 1775 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 226426 | 262390 |
| Total Cites | 179 | 179 |
| H-index | 5 | 5 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 12 | 12 |
| Total Cites to Single Authored Papers | 22 | 22 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 153 | 153 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 160 | 160 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 143 | 143 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.25 |
| Self-Citation Percentage |
0.00%
|
|
Patton, John S.
Inc,
United States
2024 Rank: 199720
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Immunology
Rank in SubField 1: 1501 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 199720 | 231270 |
| Total Cites | 159 | 160 |
| H-index | 5 | 5 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 11 | 11 |
| Total Cites to Single Authored Papers | 25 | 25 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 148 | 149 |
| Number of Single+First+Last Authored Papers | 29 | 29 |
| Total Cites to Single+First+Last Authored Papers | 149 | 150 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 127 | 128 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.25 |
| Self-Citation Percentage |
0.63%
|
|
Patton, John S.
Dance Biopharm Holdings Inc.,
United States
2023 Rank: 192847
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Immunology
Rank in SubField 1: 1463 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 192847 | 221816 |
| Total Cites | 184 | 188 |
| H-index | 5 | 5 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 21 | 21 |
| Number of Single+First Authored Papers | 21 | 21 |
| Total Cites to Single+First Authored Papers | 159 | 163 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 165 | 169 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 145 | 146 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.29 |
| Self-Citation Percentage |
2.13%
|
|
Patton, John S.
Tesio Pharmaceuticals,
United States
2022 Rank: 148916
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Immunology
Rank in SubField 1: 1092 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 148916 | 174132 |
| Total Cites | 199 | 202 |
| H-index | 5 | 5 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 10 | 10 |
| Total Cites to Single Authored Papers | 26 | 26 |
| Number of Single+First Authored Papers | 22 | 22 |
| Total Cites to Single+First Authored Papers | 170 | 172 |
| Number of Single+First+Last Authored Papers | 27 | 27 |
| Total Cites to Single+First+Last Authored Papers | 174 | 176 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 157 | 160 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.26 |
| Self-Citation Percentage |
1.49%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.